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Variations in the utilization of endovascular
aneurysm repair reflect population risk factors and
disease prevalence
Tina T. Ng, MD, James Mirocha, MS, David Magner, MD, and Bruce L. Gewertz, MD, Los Angeles, Calif
Objective:Highly variable utilization rates for a diverse group of surgical procedures are commonly ascribed to physician
practice patterns rather than clinical considerations. A previous investigation by our group showed that variations in the
rates of carotid endarterectomy (CEA) actually reflected regional risk factors for atherosclerosis, not physician density or
other socio-economic drivers. In this study, we examine the use of endovascular abdominal aortic aneurysm repair
(EVAR) over six years to test our hypothesis that the utilization of innovative vascular procedures by vascular surgeons
more closely reflects disease prevalence and consistent clinical judgment than non-medical factors.
Methods: The Nationwide Inpatient Samples and State Inpatient Databases (2001-2006) were accessed to document the
number and type of aneurysm repairs (EVAR versus open). Multiple metrics pertaining to clinical risk factors,
socioeconomic status, access to care, provider distribution, and local healthcare capacity were quantitated for each state.
We performed bivariate analysis, Pearson (PC) or Spearman (SC) correlations, and multiple regression modeling.
Results: The total number of aneurysms repaired has not changed significantly (from 45,828 in 2001 to 45,111 in 2006).
Over the same interval, the number of open AAA repair nationwide decreased by 48% while the number of AAA repaired
endovascularly increased by 105%. In 2005, the utilization rate of EVAR among 29 states ranged widely from 39.3% to
69.9%. Use of EVAR was highest in states with higher incidences of aneurysms (PC 0.43, P < .05), greater number of
deaths from heart disease (PC  0.42, P < .05), greater number of diabetes discharges (PC  0.48, P < .005), higher
number of carotid stenosis discharges (PC  0.40, P < .05), and higher number of chronic obstructive pulmonary
disorder (COPD) discharges (SC  0.43, P < .05). Regional malpractice pressure, specifically the number of paid claims
and mean malpractice premium, both exhibited positive correlations with the EVAR rate. The number of physicians,
vascular surgeons, hospital beds, teaching hospitals, or trauma centers did not predict high utilization of EVAR nor did
the other socio-economic indices tested.
Conclusion: While there was substantial regional variation in the use of EVAR, utilization of the less morbid procedure
was well correlated with higher risk populations (number of diabetic patients and deaths secondary to heart disease).
Contrary to other studies of regional discrepancies in the utilization of some surgical procedures, it appears that the
utilization of EVAR was not associated with physician distribution, socioeconomics, or other non-medical factors.
(J Vasc Surg 2010;51:801-9.)Utilization rates of some established surgical proce-
dures have demonstrated major regional variation. For
example, hip replacement, coronary artery bypass grafting
(CABG), and transurethral prostatectomy (TURP) carry a
3.5- to 4.7-fold difference across Medicare hospital referral
regions (HRR). Procedures associated with more definite
indications such as surgery for hip fractures and gall bladder
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variability.
The discrepancies in surgical care have been generally
attributed to factors other than clinical indications. These
non-clinical factors included socioeconomic factors, access
to care, provider capacity, medical malpractice pressure,
and regional physician practice styles.1-3 In a previous in-
vestigation, we utilized a national database to show that
while the rates of carotid endarterectomy (CEA) displayed
a wide difference between states, the principle driver for
variation was prevalence of cerebrovascular disease, not
physician preference or other socioeconomic factors.4
When considering the regional utilization of new pro-
cedures employing innovative technology, other variables
may become important such as training, credentialing, and
uncertain indications and outcomes. To date, little is
known regarding what medical and non-medical factors
influence the penetration of minimally invasive vascular
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aortic aneurysm repair (EVAR), into the healthcare market.
In this study, we track the use of EVAR across the United
States over a six-year period (2001-2006). We examine the
geographic variation in EVAR and correlate the differences
in procedure rates withmultiple variables representing both
medical and non-medical factors.
METHODS
To determine the temporal changes in aneurysm treat-
ment across the United States, we used the Nationwide
Inpatient Sample (NIS) and State Inpatient Databases
(SID) for the years 2001 to 2006. The NIS and SID are
databases managed by the Healthcare Cost and Utilization
Project (HCUP). The NIS is the largest all-payer inpatient
database in the United States. Information includes na-
tional estimates on hospital use for all patients from the
HCUP NIS, specifically inpatient data from all patients
discharged from member hospitals (including academic,
community, and acute-care hospitals) in the dataset. The
stratified sampling frame and discharge weights allow for
creation of accurate national estimates from the approxi-
mately 20% representative sample of all nationwide dis-
charges. Information from SID was available for 29 states
for the year 2005. EVAR data were extracted from the SID
for all available states (Appendix I, online only).
Additional detailed state-level analyses were based on
Medicare discharge data from the Dartmouth Atlas of
Healthcare 2005 report.5 The information obtained in-
cluded open abdominal aortic aneurysm (AAA) procedure
rates as well as discharge data for hypertension, chronic
obstructive pulmonary disorder (COPD), angina, diabetes,
deaths by cerebrovascular accidents, and deaths related to
heart diseases. The database accessed the Health Care
Financing Administration records relating to all inpatient
hospitalizations and procedures provided under the Medi-
care (Part A) insurance program across all 3,436 hospital
service areas (HSAs) and 306 hospital referral regions
(HRRs) in the US. Per capita rates of medical and surgical
interventionswere calculated at both theHASandHRR levels
usingMedicare Provider Analysis andReview (MEDPAR) file
hospital discharge data as the numerator and Health Insur-
ance SkeletonEligibilityWrite-Off (HISKEW)file population
data as the denominator. Medicare enrollees under age 65 or
over 99 and patient hospital stays greater than 365 days were
excluded from the data capture.
The International Classification of Diseases, Ninth Re-
vision, Clinical Modification (ICD-9-CM) coding for
EVAR changed in October 2000 so EVAR procedures
since 2001 were therefore included in the analysis. The
ICD-9-CM diagnosis codes 441.3, 441.4, and 441.9 were
used to query all patients with AAA. ICD-9-CM proce-
dures codes 38.34, 38.44, and 38.64 were used to capture
all patients who underwent open AAA repair; ICD-9-CM
code 39.71 was used for EVAR treated patients.
After initial data retrieval, we defined broad categories
of medical and non-medical factors that could potentially
influence patterns of care. Based on our literature reviewand previous investigations, we selected over 20 state-level
variables pertaining to population health surrogates, socio-
economic status, access to care, and provider distribution.
The variables were assessed from multiple public datasets
(Appendix II, online only).
We selected 2005 as our index year for detailed analysis
of economic and social variables hypothesizing that EVAR
technology would have matured by this point, some 14
years after its introduction by Parodi et al.6 The distribu-
tions of the variables were checked for normality using the
Shapiro-Wilk and Kolmogorov-Smirnov tests. The EVAR
rate distribution satisfied the normality assumption (P 
.15). Relationships between EVAR and potential predictor
variables were assessed by Pearson correlation (for normally
distributed variables) or Spearman correlation (for non-
normally distributed variables). Multiple regression models
were subsequently used to assess the overall strength of
association, using the R-squared value as the criterion.
Two-sided P-values are given for all results. Statistical anal-
yses were performed using SAS version 9.1 (SAS Institute,
Cary, North Carolina, USA). Because no protected patient
health information was involved, our Institutional Review
Board determined that this researchwas not subject to review.
RESULTS
Trends in management of AAA. From 2001 to
2006, the total number of AAA repaired remained rela-
tively stable (45,828 in 2001 to 45,111 in 2006). How-
ever, the treatment methods did change dramatically with
the number of open AAA repairs decreasing by 48% and the
proportion performed by endovascular methods increasing
by 105% (Fig 1). There was considerable variation between
states in the number of aneurysms repaired and the method
of repair. Looking at the 2005 database on Medicare ben-
eficiaries as an example, the mean rate of open AAA repair
performed for 29 states was 0.99 per 10,000 Medicare
enrollees, ranging from a low as 0.46 inHawaii to as high as
1.25 in Michigan. Yet, the degree of penetration of endo-
vascular technology was not uniform. In fact, the propor-
tion of AAA repaired by EVAR varied considerably among
states. In 2005, the utilization rate of EVAR for 29 states
averaged 54.1%, ranging from a low as 39.3% in Hawaii to
as high as 69.9% in Arizona (Fig 2).
Endovascular trends. The penetration of EVAR was
correlated with overall disease prevalence. Specifically, the
per capita number of abdominal aortic aneurysm discharges
demonstrated a significant, positive relationship with the
EVAR rate (PC  0.43, P  .05). States with higher
number of aneurysm cases had a higher proportion of
aneurysm treated by EVAR (Fig 3). Of note, the per capita
rate of open AAA repair displayed a significant, positive
relationship to the EVAR proportions (SC  0.51, P 
.005) (Fig 4).
Factors associated with EVAR distribution. Vari-
ation in EVAR was not associated with most socioeco-
nomic factors or indices of regional health care capacity.
Specifically, race, unemployment rate, poverty rate, preva-
lence of metropolitan living, median annual income, and
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rates. Likewise, the number of vascular surgeons, and non-
federal physicians, as well as per capita rates of teaching
hospitals, trauma centers, and hospital beds also displayed
no significant relationship to EVAR rates (Appendix III,
online only).
Another area of focus was regional malpractice pres-
Fig 1. Operations for abdominal aortic aneurysms (AAA
increased by 105%.
Fig 2. Percentage of AAA managed by EVAR per state
range (from 39.3 to 69.9%). Hawaii had the lowest p
(69.9%).sure. We collected state-level data on the mean malpracticeaward amount, number of paid claims (normalized per
1,000 practicing physicians), and average base malpractice
premium by general surgeons; however, data pertaining
specifically to vascular surgery practice was lacking. Of the
variables analyzed, the number of paid claims (PC  0.53,
P .005) and the mean malpractice premium (SC 0.40,
P  .05) both exhibited positive correlations with the
m 2001 to 2006. Open repairs decreased by 48%; EVAR
e year 2005 displayed a large deviation (8.2%) and wide
tage (39.3%) and Arizona had the highest percentage) froin th
ercenEVAR rate.
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surrogate markers of cardiovascular health. Specifically,
number of diabetes discharges (PC  0.48, P  .005),
number of carotid stenosis discharges (PC  0.40, P 
.05), number of COPD discharges (SC  0.43, P  .05),
and the number of deaths by coronary artery disease (PC
0.42, P  .05) all displayed significant and positive rela-
Fig 3. The percentage of AAA managed by EVAR incr
discharges increases across states (PC  0.43, P  .05).
Fig 4. The proportion of AAA managed by EVAR is str
0.51, P  .005).tionships to the EVAR rate (Figs 5-8).Not surprisingly, all four cardiovascular risk markers
(diabetes mellitus, carotid stenosis, COPD, and deaths
from heart disease) were inter-correlated, ranging from
0.42 to 0.77, P  .03 for all correlations. A multiple
regression model demonstrated that 35% of the variation in
EVAR rates was associated with the prevalence of diabetes
and the number of open AAA procedures (R2 0.346, P
as the per capita number of abdominal aortic aneurysms
correlated with the number of open AAA repair (SCeasesongly.005).
R (P
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In the data for six years reviewed, the national applica-
tion rate of EVAR substantially increased and now clearly
represents the majority of aneurysm repairs. This trend has
undoubtedly been driven by meaningful improvements in
endoluminal technology and numerous and convincing
Fig 5. The number of diabetes discharges in a given s
correlated with the percentage of AAA managed by EVA
Fig 6. The number of carotid stenosis discharges in a
(PC  0.40, P  .05).reports that EVAR is associated with reduced rates ofperi-operative morbidity as compared with open surgical
repair.7-9 In a recent review, Sadat et al found that EVAR
conferred reduction in mortality, procedure time, blood
loss, intensive care utilization, and overall hospital stay.10
At the same time, this study demonstrates that more
than 14 years after its introduction by Parodi, the penetra-
as one of the main health surrogate markers strongly
C  0.48, P  .005).
state was also strongly correlated with the EVAR ratetate wgivention of EVAR varies considerably among the states.6 In
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argue that this regional variation in utilization of EVAR is
associated with cardiovascular health risk markers and not
socioeconomic factors, provider capacity, or other non-
medical considerations. These findings concur with other
reports that demonstrated clinically appropriate application
Fig 7. The number of COPD discharges in a given sta
correlation with the EVAR rate (SC  0.43, P  .05).
Fig 8. Incidence of death secondary to coronary artery
managed by EVAR (PC  0.42, P  .05).of EVAR to higher risk patients.9-12It is also noteworthy that more frequent application of
EVAR was associated with disease prevalence (ie, states
with higher number of AAA patients have higher propor-
tions of EVAR performed). This suggests that practitioners
more frequently exposed to cardiovascular pathology are
more inclined to be “early adapters” of a relevant technol-
as another health marker that exhibited strong positive
se was strongly correlated with the percentage of AAAte wdiseaogy that facilitates selective and presumably more effective
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tional factor leading to conforming clinical practices may
also be the fact that during our defined study period, the
vast majority of endovascular repairs were performed by a
single group of specialists (vascular surgeons) with compa-
rable training and certification. This restriction in expertise
may also impact another potential source of variability –
financial incentives. Since the same physicians perform both
procedures, the decision to recommend open or endovas-
cular repair is revenue-neutral to the provider. As endovas-
cular devices become adaptable to a wider range of aortic
pathology and small enough for percutaneous delivery, the
dynamics of patient selection may change. Endovascular
repair likely will be even more favored as other practitioners
such as cardiologists and interventional radiologists be-
come more frequently involved as primary physicians in
EVAR.
Any trend toward endovascular repair would be pre-
dictably enhanced by shifts of patients to high-volume
centers. Indeed, there is considerable evidence this is oc-
curring in patients with aortic aneurysms.Hill et al analyzed
elective aneurysm repairs between 1998 and 2004 and
stratified hospitals by surgical volume (low 17 cases;
medium 18-50; high50).13 The percentage of aneurysms
repaired at low and medium volume centers fell while the
percentage performed at high volume referral centers
nearly tripled. Importantly, by 2004, 64.3% of aneurysms
repaired at high volume centers were treated with endovas-
cular techniques while only 31.8% at low volume centers
were so treated. It is noteworthy that during this time
period overall mortality of aneurysm repair decreased by
nearly a quarter. Similar trends toward increased centraliza-
tion of elective aneurysm treatment have also been seen in
Canada, with one report noting patients undergoing endo-
vascular repair were much more frequently referred from
distant regions (60%) than patients treated with open sur-
gery (20% from more remote areas).14
Socioeconomic factors. Previous investigations have
suggested that access to new surgical procedures and diag-
nostic tests might be strongly influenced by socioeconomic
factors. EVAR utilization rates have been reported to be
influenced by the number of vascular surgeons in the area,
per capita income, and insurance status.3,15 It is important
to note that the recent study by Shah et al was a “small-
area” analysis based on individual counties within southern
California.3 Referral hospitals and hence vascular surgeons
were dispersed between the confined regions. This irregular
geographic distribution of hospitals within a region may
have skewed activity of many tertiary procedures including
complex vascular repairs. Our analysis of EVAR rates in
2005 does not support these findings in the “large-area”
(statewide) samples which would tend to mask local factors
such as uneven distribution of hospitals within a state.
In our study, most socioeconomic variables (unem-
ployment rate, poverty rate, metropolitan living, median
annual income, and education level) did not significantly
influence the relative utilization of EVAR. The nature of
our study decidedly does not exclude an important effect ofinsurance status and income on outcomes of treatment. To
wit, Boxer et al looked at more than 5000 patients under 65
years of age treated over a five-year period (1995-2000)
and suggested that insurance status was, in fact, a strong
predictor of both the natural histories and outcomes of
abdominal aortic aneurysms. They noted that younger
patients without insurance or with Medicaid alone had
more than a doubling of the likelihood of presenting
with a ruptured aneurysm (odds ratio 2.3) than patients
with private health insurance. Further, the elective oper-
ative mortality of “under-insured” patients was more
than twice that of their more fortunate peers (2.7% vs.
1.2%, P  .04).16
Giacovelli et al analyzed more than 35,000 patients
treated for aneurysm in Florida and New York between
2000 and 2005 and confirmed the higher incidence of
emergent presentation in those with poor insurance.17
While they did not substantiate any reduction in survival for
either elective or emergent repair, the higher percentage of
ruptured aneurysms in the uninsured population would
predictably reduce their overall outcomes and, at least for
now, limit the use of EVAR. This may change as more
reports of favorable results in ruptured aneurysms accumu-
late and more hospitals offer such services.18
Race. When considering the relative utilization of en-
dovascular aneurysm repair, neither our study nor the ear-
lier work by Shah et al demonstrated any significant effect
of race.3 This varies from a number of other studies that
suggest that African Americans and other minorities are at a
disadvantage with regards to access to a wide range of
cardiovascular services, especially emerging medical tech-
nologies.19 In several well-designed studies, minorities
were seen to be significantly less likely to undergo CABG or
percutaneous transluminal angioplasty than white patients
within disease-matched appropriateness strata.20-22 An
early study of racial variation in the use of surgical proce-
dures in Massachusetts in 1988 noted that procedure rates
were higher in Whites for 8 out of 10 procedures studied
including open repair of abdominal aortic aneurysms. They
further observed that these variations did not reflect
whether procedures were “high-discretion,” requiring
much practitioner judgment or “low-discretion,” with well
delineated indications.23
These disparities could be identified in our previous
work on carotid endarterectomy in which we found that
as the percentage of non-white population increases in a
state, the per capita rate of CEA performed decreases.
That said, interpretation of these relationships is not
straightforward. While one reasonable conclusion might
be that vascular interventions are under-utilized among
minority groups, alternative explanations (more frequent
small-vessel disease in Blacks with pathology not amena-
ble to CEA or even over-utilization of CEA in Whites)
are also possible.4
The complexity of these issues is further illustrated by a
thoughtful study by Wilson et al. UsingMedicare data over
a two year period (2001-2002), they assessed the incidence
of both elective and emergent aortic aneurysm repairs in
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prevalence based on data derived from the Aneurysm De-
tection and Management Veteran Affairs Cooperative
Study (ADAM) and smoking status. Using this statistical
methodology, the adjusted risk of aortic aneurysms in black
men 65 years or older was 39% lower than in Whites. Even
after adjusting for incidence, they found that the utilization
of elective aneurysm repair was still lower than would be
predicted in Blacks (29%). Further, the incidence of repair
for ruptured aneurysm was relatively higher in Blacks (52%
of that seen in Whites) strongly suggesting an under utili-
zation of elective repair.24
Others using similar databases have noted that race
significantly impacts outcomes from EVAR.25 Specifically,
Blacks and Hispanics were more likely to experience peri-
operative mortality and postoperative complications than
white patients. However, this study did not consider the
balance between open and endovascular repair and noted
that the sample had a very high proportion of white patients
(91.24%) and potentially an incomplete accounting of im-
portant risk factors such as diabetes.
Finally, Vogel and colleagues assessed 6227 patients
undergoing aneurysm repair in New Jersey between 2001
and 2006. White and black patients had the same chance of
undergoing EVAR and both groups were 60% more likely
to undergo EVAR than Hispanics (odds ratio 1.6). During
this five-year period, which corresponded to a rapid in-
crease in the utilization of endovascular techniques, unin-
sured and Hispanic patients were significantly less likely and
older males were significantly more likely to be treated with
EVAR. As noted by Wilson and referenced above, Blacks
had a significantly greater likelihood of peri-operative mor-
tality even after elective repair.15,24
Provider capacity. Provider capacity refers to the abil-
ity of a region to accommodate treatment of a given disease
burden. Markers for provider capacity include the number
of primary and specialty physicians per capita and the re-
gional capacity of the health care networks including hos-
pital beds, trauma centers, and outpatient clinics. In previ-
ous analyses of many diverse disease processes with multiple
treatment options, physicians have been shown to over-
whelmingly recommend the treatment associated with
their specialty.26-28 In addition, procedure rates and office
visits have been correlated with the per capita availability of
specialists in an area.29 It would be intuitive that states with
more resources and specialists would have higher percent-
age of EVAR performed. As noted above, the prior study by
Shah et al with regional data from Southern California
demonstrated that the proportion of EVAR was higher in
regions with more vascular surgeons.3
In our study, we analyzed the distribution of vascular
surgeons and nonfederal physicians and neither had a con-
sistent association with EVAR rates. Furthermore, states
with more facility capacity and academic resources (namely,
more hospital beds, teaching hospitals, and trauma centers)
did not, in general, have higher EVAR rates. Due to the
character of our data, our results do not refute the region-
alization effect noted earlier (ie, more EVAR in higher-volume centers) but simply indicates that grouping into
larger statewide databases can obscure subtle regional dif-
ferentials within a given state.
Malpractice. It is often challenging to accurately
quantitate the effects of local medical liability climate on
treatment decisions. Difficulties begin with the multiple
but inexact financial metrics (eg, number of paid claims,
paid claims per physician, or malpractice premiums), which
often do not allow for specialty specific comparisons. Ad-
ditional descriptive data obtained from surveys of physi-
cians regarding their motivation and decision-making often
has considerable bias. Still, there is considerable sentiment
that physician diagnostic and therapeutic recommenda-
tions are strongly influenced by medical liability exposure
for such diverse health issues as heart disease (performance
of coronary angiograms), carotid artery disease (indications
for carotid duplex scanning), and pregnancy (incidence of
cesarean deliveries).
The decision to perform aneurysm repair by open sur-
gical or endovascular means would not seem likely to be
strongly influenced by physician malpractice concerns.
Nonetheless, the number of paid claims and mean malprac-
tice premiums of general surgeons both exhibited positive
correlations with EVAR use. More detailed information,
especially focused on vascular surgeons’ decision making
and their perceptions of the influence of liability threats
would be needed to determine the importance of these
correlations.
Limitations. Like all retrospective studies, this study
has a number of limitations. Our analysis necessarily relies
on the information obtained from multiple databases from
different years. We recognized that information from mul-
tiple databases, including the NIS and Dartmouth Atlas of
Healthcare, were extrapolated for analysis. Although the
patient populations captured do differ between the data-
bases, aneurysmal disease generally affects the elderly pop-
ulation so the impact of this discrepancy is likely minimal.
We used the NIS mainly for the purpose of extracting data
on treatment modalities (EVAR versus open AAA repair)
and theDartmouth Atlas database for information of health
disease markers across the states.
As well, these inpatient databases include only 60% of
the country although these 29 states are more or less
equally distributed among all regions of the country. A
more important limitation is the fact that utilization of
statewide data may be insensitive to important relationships
within states. This would be especially true for certain
socio-economic indicators (such as personal income),
which may be “homogenized” across an entire state. For
instance, two states with the same median annual income
(such as Nebraska and New York) but with very different
income distributions (eg, homogeneous vs. widely distrib-
uted) would be indistinguishable from each other. Finally,
while multiple medical and socio-economic variables were
examined in this investigation, there are likely other impor-
tant factors that need to be explored.
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This survey of EVAR use in the United States over six
years demonstrates that, despite the progressive utilization
of this innovative technique, there is still considerable vari-
ation between states. The key observation of this study is
that higher EVAR use correlated most closely with higher
risk patient populations and increase experience in treating
aneurysms. Specifically, use was not strongly influenced by
many of the socio-economic measures thought to be pre-
dictive of the utilization of new technology. The appropri-
ate matching of EVAR use with clinical indications may be
explained by the fact that during the study period a single
specialty (vascular surgery) was responsible for carrying out
virtually all treatments for aortic aneurysm disease.
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April 2010809.e1 Ng et alAppendix III, online only. Listing of variables that did
not demonstrate significant correlation with endovascular
abdominal aortic aneurysm repair (EVAR) rate
Variable
Correlation
coefficient,
Pearson (PC) or
Spearman (SC) P
Race (percentage of nonwhite population) SC  0.10 .59
Unemployment rate PC  0.12 .54
Poverty rate PC  0.25 .19
Prevalence of metropolitan living PC  0.10 .61
Median annual income PC  0.12 .53
Education level (bachelor level or higher) PC  0.05 .81
Number of vascular surgeons PC  0.19 .33
Number of non-federal physicians SC  0.05 .78
Number of hospital beds PC  0.18 .36
Number of teaching hospitals SC  0.31 .11
Number of trauma centers SC  0.10 .60
Mean malpractice award PC  0.18 .35Appendix I, online only. Rank-order listing of percentage
of abdominal aortic aneurysm managed by endovascular
abdominal aortic aneurysm repair for 29 states (2005)
State EVAR percentage
Hawaii 39.3%
Minnesota 41.7%
Iowa 42.6%
Wisconsin 44.8%
Oregon 45.9%
Colorado 46.2%
Nevada 46.5%
Massachusetts 47.2%
Utah 48.2%
North Carolina 49.7%
Oklahoma 50.1%
Arkansas 50.1%
California 50.2%
Rhode Island 54.7%
Washington 55.1%
Florida 55.8%
Michigan 55.9%
Nebraska 56.4%
Tennessee 56.6%
Kansas 57.9%
Missouri 59.1%
Kentucky 59.8%
New Hampshire 60.9%
South Carolina 60.9%
New York 64.9%
West Virginia 66.5%
New Jersey 66.5%
Maryland 66.5%Appendix II, online only. Endnotes
i. Variables of race (2006-2007), unemployment (2007),
households in poverty (2005), median annual income (2004-
2006), percentage with Bachelor’s degree (2006), metropoli-
tan versus rural living (2005-2006), total and mean malprac-
tice award (2007), number of paid claims per 1,000 MDs
(2007), total practicing non-federal physicians (2007), num-
ber of hospital beds per capita (2006), percentage of adult
smokers (2006), death due to stroke (2003) and death sec-
ondary to coronary artery disease (2003) were gathered from
www.statehealthfacts.org and the U.S. Census Bureau.
ii. Values of the mean medical malpractice premium of General
Surgeons (2003) were obtained from Medical Liability Mon-
itor, The Survey. Oct. 2003;28(1):1-20.
iii. The 2007 listing of American Board of Survey Vascular Dip-
lomats supplied the number of vascular surgeons per state.
iv. Data on teaching hospitals were obtained from the Associa-
tion of American Medical Colleges, Member Teaching Hos-
pitals and Health Systems (http://services.aamc.org/
memberlistings).
v. Data on trauma centers (all levels) were obtained from the
American Trauma Society (http://www.amtrauma.org/tiep/
